Company Filing History:
Years Active: 2015
Title: Guohua Dai: Innovator in Chinese Medicine for Cardiac Health
Introduction
Guohua Dai is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of medicine, particularly in the use of traditional Chinese medicine for modern health applications. His innovative approach combines ancient practices with contemporary medical needs.
Latest Patents
Guohua Dai holds a patent for the "Use of a Chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction." This invention focuses on a specific Chinese medicine composition that is formulated from various crude drugs. The composition includes Radix Astragali (22.2%–66.8%), Radix Salviae Miltiorrhizae (11.6%–33.4%), Radix Notoginseng (2.5%–13.5%), and Lignum Dalbergiae Odoriferae (14.5%–44.3%). This patent highlights his commitment to integrating traditional remedies into modern healthcare solutions.
Career Highlights
Guohua Dai is associated with Tasly Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical industry. His work at Tasly has allowed him to explore and develop innovative medicinal products that leverage the benefits of traditional Chinese medicine. His dedication to research and development has positioned him as a key figure in the field.
Collaborations
Guohua Dai has collaborated with notable colleagues, including Boli Zhang and Hongcai Shang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medicinal research.
Conclusion
Guohua Dai's contributions to the field of medicine, particularly through his innovative patent, demonstrate the potential of traditional Chinese medicine in addressing modern health challenges. His work continues to inspire advancements in cardiac health and beyond.